Two Sigma Investments, LP Ginkgo Bioworks Holdings, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $1.16 $5.4 Million - $22.4 Million	19,297,462 Added 17054.46%	19,410,614 $6.41 Million
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $123,053 - $193,866	-116,088 Reduced 50.64%	113,152 $131,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $804,784 - $1.14 Million	-638,718 Reduced 73.59%	229,240 $387,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $1.4 Million - $2.2 Million	867,958 New	867,958 $1.57 Million
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $2.24 Million - $4.09 Million	-1,867,874 Reduced 89.29%	224,000 $297,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $3.41 Million - $7.36 Million	2,091,874 New	2,091,874 $3.54 Million
Q2 2022 Aug 15, 2022	SELL	$2.2 - $4.2 $127,756 - $243,898	-58,071 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $164,340 - $504,636	58,071 New	58,071 $234,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.